Elon Musk, founder of Neuralink, said in a podcast with Lex Fridman that the second case has gone well so far, the report said. Mr. Musk predicted that in the future, the number of electrodes in Neuralink implants will increase to improve signal processing.
Neuralink, which is designed to help spinal cord injury patients, was first implanted in a human patient in January. The implant helped that patient improve his quality of life.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
